Search research articles
Contact Us
Filters
Showing results (361-370 of 555) with videos related to
Page
of 56
Sort By:
Transplantation
|
March 15, 1996
Direct activation of porcine endothelial cells by human natural killer cells
D J Goodman, M Von Albertini, A Willson, et al.
Cancer Research
|
February 15, 1989
Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets
A C Ochoa, D E Hasz, R Rezonzew, et al.
Transactions of the Association of American Physicians
|
January 1, 1987
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2
D Kotasek, G M Vercellotti, A C Ochoa, et al.
Tissue Antigens
|
January 1, 1973
Importance of different regions of H-2 for MLC stimulation
M B Widmer, C Omodei-Zorini, M L Bach, et al.
Scandinavian Journal of Immunology
|
January 1, 1977
Lack of restimulation by non-HLA antigens in primed lymphocyte typing
C Y Shih, E A Valentine, M J Sheehy, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
May 1, 1992
Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck
D S Cross, J L Platt, S K Juhn, et al.
Nature
|
July 20, 1978
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells
J M Zarling, H I Robins, P C Raich, et al.
Immunological Reviews
|
October 1, 1994
Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies
D Latinne, M Soares, X Havaux, et al.
The Journal of Experimental Medicine
|
August 1, 1980
Cloned primed-lymphocyte-test reagents in the dissection of HLA-D
H Inouye, J A Hank, X Chardonnens, et al.
Lancet (London, England)
|
November 24, 1984
HLA C associations with acute leukaemia
J D'Amaro, F H Bach, J J Van Rood, et al.
Page
of 56
Search research articles
Search
Showing results (361-370 of 555) with videos related to
Sort By:
Page
of 56
Transplantation
|
March 15, 1996
Direct activation of porcine endothelial cells by human natural killer cells
D J Goodman, M Von Albertini, A Willson, et al.
Cancer Research
|
February 15, 1989
Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets
A C Ochoa, D E Hasz, R Rezonzew, et al.
Transactions of the Association of American Physicians
|
January 1, 1987
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2
D Kotasek, G M Vercellotti, A C Ochoa, et al.
Tissue Antigens
|
January 1, 1973
Importance of different regions of H-2 for MLC stimulation
M B Widmer, C Omodei-Zorini, M L Bach, et al.
Scandinavian Journal of Immunology
|
January 1, 1977
Lack of restimulation by non-HLA antigens in primed lymphocyte typing
C Y Shih, E A Valentine, M J Sheehy, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
May 1, 1992
Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck
D S Cross, J L Platt, S K Juhn, et al.
Nature
|
July 20, 1978
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells
J M Zarling, H I Robins, P C Raich, et al.
Immunological Reviews
|
October 1, 1994
Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies
D Latinne, M Soares, X Havaux, et al.
The Journal of Experimental Medicine
|
August 1, 1980
Cloned primed-lymphocyte-test reagents in the dissection of HLA-D
H Inouye, J A Hank, X Chardonnens, et al.
Lancet (London, England)
|
November 24, 1984
HLA C associations with acute leukaemia
J D'Amaro, F H Bach, J J Van Rood, et al.
Page
of 56